Drug
Cabazitaxel
Cabazitaxel: highest development phase Phase 2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Cabazitaxel NCT01541007 | Phase 2 | Metastatic Castration Resistant Prostate Cancer |
Latest
No recent events.
Follow Cabazitaxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.